COLL vs TFC · P/E 17, rev $181.9M vs rev $24.54B
Collegium Pharmaceutical Inc (COLL) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
TFC (TFC) common stock.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported TFC revenue for 2025-12-31 was $24.54B. Net income was $5.31B. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. TFC currently screens at market cap $0.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. TFC currently screens at market cap $0.
Not investment advice. Open the COLL and TFC stock pages for the full models.
Not investment advice.